Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer
2025 · Journal of Controlled Release · 6 citations
https://doi.org/10.1016/j.jconrel.2025.114269
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
13
Citations
2
h-index
0
i10-index
Natalia Ćwilichowska-Puślecka is an academic researcher from Wrocław University of Science and Technology. The author has contributed to research in topics: HER2/EGFR in Cancer Research & COVID-19 Clinical Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 5 publications.
https://doi.org/10.1016/j.jconrel.2025.114269
https://doi.org/10.1186/s13046-025-03554-w
Click to start Chat